Two emerging pathogens with animal origins—influenza D virus and canine coronavirus—have so far been quietly flying under the radar, but researchers warn conditions are ripe for the viruses to spread more widely among humans. If surveillance and diagnostics continue to lag, influenza D virus and canine coronavirus have real potential to trigger outbreaks, writes a team of infectious disease experts and authors.
The work appears in Emerging Infectious Diseases.
“Our review of the literature indicates these two viruses pose respiratory disease threats to humans, yet little has been done to respond to or prevent infection from these viruses,” said co-author John Lednicky, Ph.D., a research professor in the Department of Environmental and Global Health at the University of Florida’s College of Public Health and Health Professions.
“If these viruses evolve the capacity to easily transmit person to person, they may be able to cause epidemics or pandemics since most people won’t have immunity to them.”
Since its discovery in 2011, influenza D virus has been associated with infections in pigs and cows, but it has also been found in many other livestock and wildlife species, including poultry, deer, giraffes, and kangaroos. Influenza D virus is believed to contribute to bovine respiratory disease, estimated to cost the U.S. cattle industry $1 billion a year.
The authors’ previous studies of cattle workers in Colorado and Florida found that up to 97% of people working with herds carry influenza D virus antibodies, suggesting the workers had been exposed to the virus. So far, these infections are known to be subclinical, meaning they have not caused symptoms of illness. However, scientists say influenza D virus bears the hallmarks of a virus primed to rapidly evolve. Indeed, a strain of influenza D recently isolated in China has developed the capacity for human-to-human transmission.
“So far, influenza D virus has not been associated with serious infections in humans,” said Lednicky, a member of UF’s Emerging Pathogens Institute. “However, canine coronavirus has, but diagnostic tests are not routinely performed for the virus, so the extent to which the virus affects the population at large is not known.”
Canine coronavirus (CCoV) can cause gastrointestinal illness in dogs, and is not the same virus as SARS-CoV-2, the virus that causes COVID-19. Documented canine coronavirus infections in humans, while still rare, have been linked to pneumonia hospitalizations in Southeast Asia.
In a 2021 study led by Lednicky, a UF team isolated a canine coronavirus from a medical team member who had traveled from Florida to Haiti in 2017 and later experienced mild fever and malaise. The team named the strain HuCCoV_Z19Haiti.
Scientists led by Gregory Gray, M.D., director of the One Health Research and Training Laboratory at the University of Texas Medical Branch, reported the discovery of a new canine coronavirus strain, CCoV-HuPn-2018, in 2021. The strain had been isolated from a child hospitalized in Malaysia and was nearly identical to the coronavirus discovered by the UF team.
Since then, CCoV-HuPn-2018 has been found in people with respiratory illness living in Thailand, Vietnam, and in the state of Arkansas, demonstrating that this strain of canine coronavirus is already circulating across continents.
These recent influenza D virus and canine coronavirus discoveries underscore a familiar lesson from recent pandemics: Without proper preparation, a virus that quickly gains efficient human-to-human transmissibility can easily turn into a large-scale human epidemic. To prevent such a scenario, the scientists say better virus monitoring, more reliable tests, treatments, and possible vaccines are needed.
“Our knowledge of the viruses’ epidemiology and clinical manifestations is limited to a modest number of research studies,” the authors wrote. “Even so, the limited data regarding these novel, newly detected viruses indicate that they are a major threat to public health.”
Publication details
Gregory C. Gray et al, Emerging Respiratory Virus Threats from Influenza D and Canine Coronavirus HuPn-2018, Emerging Infectious Diseases (2026). DOI: 10.3201/eid3201.251764
Journal information: Emerging Infectious Diseases
News
COVID-19 can wake up dormant viruses in the body, large study confirms
Virus reactivations by SARS-CoV-2 could worsen initial symptoms and increase risk of Long Covid. Early in the COVID-19 pandemic, scientists noticed that a SARS-CoV-2 infection can “wake up” other, dormant viruses already present in [...]
Scientists Discover the Brain May Enter a New Biological Phase Between 50 and 75
A single-cell study reveals major changes in immune cells, genome organization, and gene regulation within the aging human hippocampus, offering important insights into brain aging and dementias associated with age. Between roughly ages 50 [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Unzipping the Code of Life: Scientists Pinpoint Where DNA First Opens
Researchers mapped where DNA first opens and how a helicase gate may release one strand as genome copying begins. Before a cell can divide, it must open its tightly wound DNA and begin copying the entire [...]
Scientists Tested an 8-Hour Eating Window and Found a Surprising Brain Benefit
Limiting the daily eating window may provide brain benefits beyond those associated with weight loss. Eating within a shorter daily window may provide cognitive benefits beyond those associated with weight loss alone, according to [...]
Focused Ultrasound Opens Blood-Brain Barrier to Treat Brain Cancer
Summary: A new study demonstrates that primary brain tumors (gliomas) are particularly receptive to targeted drug delivery using focused ultrasound (FUS) combined with microbubbles. The team developed a high-resolution MRI protocol to track blood-brain barrier [...]
AI’s promise and practical limits in drug discovery
AI tools are becoming increasingly common in early drug discovery, allowing scientists to analyse data and navigate large volumes of research. However, according to Dr Raminderpal Singh, turning that potential into consistent scientific workflows [...]
GHCE Concept
From the preface of the book Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence, Edited by Frank Boehm: Since the publication of my first book (Nanomedical Device and Systems [...]
Healthcare Headlines: Challenges and Advances in 2026
Health-related updates reveal financial adjustments by Universal Health Services due to Medicaid reimbursement uncertainties, significant pollution-linked health concerns from French-British oil firm Perenco in Congo, drug trial setbacks, potential restructuring at major medical firms, [...]
Scientists Discover the Brain Protein That Helps Alzheimer’s Spread Through the Brain
Scientists have identified a brain protein that may help Alzheimer’s spread, revealing a potential new target for slowing the disease’s progression. Alzheimer’s disease is closely linked to the accumulation of a toxic form of the protein [...]
How Immune Dysregulation Contributes to Psychiatric Disorders
Introduction Growing evidence suggests that disruptions in immune function may play an important role in the development and progression of psychiatric disorders. However, immune mechanisms probably contribute more strongly in some patients than others, [...]
Electrostatic Discharge Boosts Triboelectric Nanogenerator Current and Enables DC Output
Controlled electrical discharges could enable triboelectric nanogenerators to achieve higher peak currents, extending nano-enabled energy harvesting into chemical processing and self-powered sensing. Paper: Electrostatic discharge as a breakthrough strategy for triboelectric nanogenerators. A new review [...]
Swiss laboratory uses old drugs against rare diseases
Researchers at the University of Geneva are combing through collections of approved drugs to find new therapies for rare diseases – with some success. This approach is gaining traction around the world, while pharmaceutical [...]
Nanozyme Aptasensors Show Promise for Faster Food, Health, and Environmental Testing
By pairing robust artificial enzymes with highly selective aptamers, nanozyme aptasensors could help detect disease biomarkers, pathogens, and contaminants faster, but the review shows that real-world deployment still depends on overcoming matrix interference, biofouling, [...]
Paralyzed Man Feels Sensation Again With Brain Stimulation Device
Aneuroprosthetic system has allowed a man with paralysis to grasp and lift objects and feel touch again. The device helped 42-year-old Keith Thomas of Massapequa, New York, who was paralyzed from the chest down [...]
Global Cancer Cases Could Surge 67% by 2050, New Report Warns
New data reveal major geographic disparities and highlight the urgent need for global action on prevention, early detection, and equitable access to treatment. For roughly one in five people worldwide, cancer will become part [...]















